Welcome to The Symptoms Of Multiple Sclerosis
Multiple Sclerosis And Physical Therapy Article
This is a selection among article about Multiple Sclerosis And Physical Therapy. For a permanent link to this article, or to bookmark it for further reading, click here.
Life-Saving Pediatric Drug Becomes Readily Available to Those in Need
from: By: ARA Content(ARA) - We can all sympathize with the frustration people experience waiting for a new drug that is being tested for a certain disorder. Imagine you have a child with a rare disorder and the only drug effective for treating the disorder is not only extremely hard to obtain, but available only through a nationally-administered random selection process. For many American families, this dilemma is a harsh reality.
Patients suffering from a host of difficult to treat orphan disorders have found marked relief from using HP Acthar Gel. Some disorders Acthar helps include seizure complex in babies and young children, referred to as West's syndrome or infantile spasm; Still's disease and ulcerative colitis; Bell's palsy; multiple sclerosis; adrenocortical insufficiency and non-endocrine disorders that are responsive to glucocorticoids.
For the past four years, however, the drug has only been available through a limited access program administered by the National Organization for Rare Disorders (NORD), a federation of more that 135 non-profit health organizations serving people with rare disorders.
U.S. physicians who were interested in obtaining Acthar Gel for their patients with life-threatening or severely debilitating conditions who did not respond to any other treatment were given first access to the drug. Others with "non-life-threatening" cases had to enroll in a computerized random selection process administered by NORD.
An estimated 1,600 patients, primarily suffering from West's syndrome and multiple sclerosis who experience episodes of "flare," have been allowed access to HP Acthar Gel each year for the past four years under the limited access program. More than 5,000 additional patients whose physicians requested the drug were denied.
The origins of this drug shortage crisis date back to 1996 when Aventis Pharmaceuticals stopped making Acthar for a few months because of manufacturing difficulties.
But now, Questcor Pharmaceuticals, Inc. (AMEX: QSC) has signed an agreement with Aventis to acquire the worldwide rights to HP Acthar Gel. Questcor has also reached a manufacturing agreement with Aventis and will gradually move production to an independent manufacturing facility.
As a result, HP Acthar Gel is now back in full production and is returning to normal levels of distribution. Questcor began shipments of HP Acthar Gel to wholesalers the last week of September 2001, giving patients in need access to the product.
"We are delighted that Questcor is making this critically important product more widely available after this long period of restricted distribution," said Abbey S. Meyers, president of NORD. "We have been working closely with the company over the last several months to ensure that anyone with a need for Acthar Gel is now able to readily receive the product through more traditional channels. Too many people have suffered as a result of limited access to Acthar Gel."
Questcor Pharmaceuticals, Inc. is a fully integrated specialty pharmaceutical company that serves the needs of acute and critical care hospitals with its proprietary products. Visit www.questcor.com for more information on the company and its products.
If you are a patient with a disorder that can be treated with Acthar, ask your doctor to contact Questcor Pharmaceuticals at (510) 400-0700. For more information about Acthar, including distribution information, please visit www.Acthar.com.
About The Author Courtesy ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com |
This article was posted on January 17, 2002
Multiple Sclerosis And Physical Therapy News
NORCO: New center aims to heal with horses - Press-Enterprise
 Press-Enterprise | NORCO: New center aims to heal with horses Press-Enterprise Pediatric physical therapist Cassandra Sanders-Holly helps Evan Bravo, 3, of Ontario up a ramp to mount a horse at Leaps & Bounds In Norco where the young cerebral palsy patient receives alternative physical therapy. At right are volunteers Miranda ... |
AquaHab Physical Therapy Case Study Supports New Findings on the Benefits of ... - DigitalJournal.com (press release)
AquaHab Physical Therapy Case Study Supports New Findings on the Benefits of ... DigitalJournal.com (press release) His past medical history included a total hip replacement in 2009 and a lumbar laminectomy in 2008, as well as hypertension and Multiple Sclerosis (MS). While AquaHab Physical Therapy offers both aquatic and land therapies, the patient's therapist ... |
Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves ... - MarketWatch (press release)
Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves ... MarketWatch (press release) "The majority of the nearly seven million people in the United States who live with the long term effects of a stroke have motor function deficits, such as walking impairment, but there are no established treatments other than physical therapy to ... |
Investigating Fingolimod for Multiple Sclerosis - Ivanhoe
Investigating Fingolimod for Multiple Sclerosis Ivanhoe Patients affected by multiple sclerosis are hindered on a daily basis by physical ailments, including fatigue, pain, and difficulty with mobility, as well as problems with social functioning and impaired mood. The Food and Drug Administration (FDA) ... |
Man riding scooter from Canterbury to the Arctic for charity - This is Kent
Man riding scooter from Canterbury to the Arctic for charity This is Kent "The therapy centre was like a lifeline to me when I was ill five years ago. They gave mental and physical support, and made my life a lot more tolerable." Diagnosed in 1999, Steve has learnt to live with MS, but suffered a relapse five years ago ... |
Small business development & consulting firm.